Sebastian Oehm

Sebastian Oehm is the co-founder and CEO of SynX Therapeutics, a biotech start-up developing non-natural peptides as next-generation medicines. He is also an Adjunct Assistant Professor at the J. Craig Venter Institute, and a Research Fellow at RAND Europe. He was one of 38 scientists who first publicly warned of the risks from mirror life. Previously, he completed a PhD and postdoc at the MRC LMB / University of Cambridge, where his research focused on non-natural biology. He worked as a staffer in the German parliament, and earned a BA in Natural Sciences at the University of Cambridge.